NCT03205722View on ClinicalTrials.gov

The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 5, 2018

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Melanoma
Interventions
OTHER

Non-Interventional

Non-Interventional

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY